C
CIN Terminal
Cannabis Investor News
A CanIDeal Company
All Insights
J
HoldCIN Rating 57/100How is this calculated?

TLRY Sets the Global Cannabis Macro Test

Tilray’s fiscal 2027 guidance puts cash conversion—not headline revenue—at the center of global cannabis positioning as risk appetite remains selective across North America and Europe.

Key takeaways
    Share X LinkedIn Email
    Found this useful? Share it X LinkedIn

    More like this, straight to your inbox

    One new CIN Insight + the week's top three signals from the live terminal. Free, weekly.